Results 10,421-10,440 of 12,424 for speaker:Louise O'Reilly

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: Would Ms Spillane like to respond to the questions thus far?

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: Is Ms Spillane suggesting the HSE does not provide services between 5 p.m. and 7 p.m. or that there is a particular need between those hours that only the private sector can meet?

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: We will get an opportunity to discuss the constraints on the voluntary providers later. As someone who represented home help staff in a previous life, I would count the directly employed home help staff in the HSE as among the most flexible in the workforce. I would question anyone in the HSE who might make that assertion. I will get a chance to ask my questions in a little while.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: There is a hybrid model in operation involving public, private and voluntary actors. Let us consider the value for money argument. For example, let us suppose every penny spent by the HSE was invested in front-line care. The same would be true of voluntary bodies, most of which are run on a shoestring and they do not have fancy offices or cars, though the large private agencies have shiny...

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: That is what we were saying. Many people fit in the work of caring, which is work and should not be called anything else even if done for people we love, with other work and we need to make that distinction.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: That would be very helpful. There is a distinction to be made between those who do it and fit it in with other work and those for whom it is their primary activity.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: Sorry to interrupt. It is in the case that there is a marked difference in the hourly rate of pay and the rate charged between the private and public sector.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: I do not think it is huge, Senator, but I do not know, which is why I am asking.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: I am aware of that and I have examined it myself. I have come to my own conclusion but want to ask our witnesses to provide some more information.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: We will move on to the service-level agreement, SLA, as a mechanism to regulate and monitor. How does that work?

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: Could we get all the questions answered and then we might have a chance for a supplementary?

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: We will go through the bank of questions that we have and then come back to that at the end if that is agreeable.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: On behalf of the committee, I thank Ms Frances Spillane and Mr. Robert Deegan of the Department and Dr. Jean Long of the Health Research Board for attending and indeed sharing their valuable expertise with us.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: The purpose of this session is to engage with representatives from Age Action Ireland, the National community Care Network and a health economist, who is not with us just yet. as we continue our examination of rights, resources and regulation of home care. On behalf of the committee I welcome Mr. Justin Moran of Age Action Ireland, Ms Maria Jackson and Mr. Fiacre Hensey of the National...

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: I invite Professor O'Shea to address the joint committee.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: I thank Professor O'Shea. I call on Ms Jackson if she would like to make her opening remarks.

Joint Oireachtas Committee on Health: Home Care - Rights, Resources and Regulation: Discussion (15 Nov 2017)

Louise O'Reilly: I have a number of short questions. Unfortunately, I will have to leave for a couple of minutes so Deputy Durkan will take the Chair. I will ask my questions and will have an opportunity to read back on the answers in the Official Report. Mr. Moran talked about the need to maintain standards and how important they are, and I do not think anyone would disagree with that. Can Mr. Moran...

Written Answers — Department of Health: Industrial Disputes (15 Nov 2017)

Louise O'Reilly: 36. To ask the Minister for Health the position regarding the possibility of a strike by workers in section 39 agencies; the steps that he has taken to address the underlying issues which may lead to a strike; his plans to unwind the FEMPI cuts imposed on section 39 agencies; and if he will make a statement on the matter. [48113/17]

Written Answers — Department of Health: General Practitioner Contracts (15 Nov 2017)

Louise O'Reilly: 56. To ask the Minister for Health the position regarding the negotiations on a new general practitioner contract; when the negotiations are expected to finalised; the substantive changes which the contract is expected to entail; and if he will make a statement on the matter. [48115/17]

Written Answers — Department of Health: Medicinal Products Reimbursement (15 Nov 2017)

Louise O'Reilly: 99. To ask the Minister for Health his views on the need for a dedicated policy for the approval and reimbursement of orphan drugs for rare diseases, which is separate to the current policy, in view of the fact that the national rare disease plan for Ireland 2014-2018 recommended the bringing forward of appropriate decision criteria for the reimbursement of orphan rare medicines and...